{"id":"W4390637832","doi":"10.1007/s12325-023-02719-3","title":"Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Bayer","keywords":"Aflibercept; Medicine; Macular degeneration; Dosing; Randomized controlled trial; Rheumatology; Ophthalmology; Bevacizumab; Internal medicine; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004701649,0.001284908,0.002410513,0.0005466926,0.0004751773,0.001461918,0.0009107834,0.001791033,0.006095077],"category_scores_gemma":[0.003023996,0.0005433977,0.00271288,0.0003858908,0.0009229589,0.001310764,0.000598072,0.002771287,0.0005959933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005994184,"about_ca_system_score_gemma":0.0007774411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005809244,"about_ca_topic_score_gemma":0.001558283,"domain_scores_codex":[0.9981514,0.001117496,0.0001309439,0.0002816721,0.0001509034,0.0001677286],"domain_scores_gemma":[0.9982725,0.0006908859,0.0004243349,0.0001778775,0.00009203851,0.0003423827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9868944,0.002400235,0.0005059581,0.0002359367,0.000864975,0.00001354622,0.00002520703,0.0002005069,0.001114267,0.0001034336,0.0003369567,0.007304679],"study_design_scores_gemma":[0.9511788,0.04468405,0.001995633,0.0000330279,0.0008073203,0.00002231545,0.00001037958,0.0004158212,0.0001996624,0.0001309822,0.0005098956,0.00001209256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785245,0.009235671,0.001054238,0.0007478942,0.0005071903,0.004544908,0.001925984,0.0001196571,0.003339848],"genre_scores_gemma":[0.9871511,0.002343844,0.001656513,0.0009151791,0.0006682281,0.003594677,0.001393863,0.00001393497,0.002262735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006095077,"threshold_uncertainty_score":0.02486497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01396796621224704,"score_gpt":0.3149791968651613,"score_spread":0.3010112306529143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}